Global Oral Antidiabetic Agents Market Growth (Status and Outlook) 2022-2028

January 2021 | 100 pages | ID: G1E14E36D39EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Oral Antidiabetic Agents will have significant change from previous year. According to our (LP Information) latest study, the global Oral Antidiabetic Agents market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Oral Antidiabetic Agents market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Oral Antidiabetic Agents market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Antidiabetic Agents market, reaching US$ million by the year 2028. As for the Europe Oral Antidiabetic Agents landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Oral Antidiabetic Agents players cover Novo Nordisk, Eli Lilly, Sanofi, and Roche, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Antidiabetic Agents market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

• Sulfonylureas
• Meglitinides
• Biguanides
• Thiazolidinediones
• Alpha-glucosidase Inhibitors

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

• Home Use
• Medical Institutions
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• Novo Nordisk
• Eli Lilly
• Sanofi
• Roche
• Teva
• AstraZeneca
• Wockhardt UK
• Merck
• Pfizer
• Cipla

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral Antidiabetic Agents Market Size 2017-2028
  2.1.2 Oral Antidiabetic Agents Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Oral Antidiabetic Agents Segment by Type
  2.2.1 Sulfonylureas
  2.2.2 Meglitinides
  2.2.3 Biguanides
  2.2.4 Thiazolidinediones
  2.2.5 Alpha-glucosidase Inhibitors
2.3 Oral Antidiabetic Agents Market Size by Type
  2.3.1 Oral Antidiabetic Agents Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Oral Antidiabetic Agents Market Size Market Share by Type (2017-2022)
2.4 Oral Antidiabetic Agents Segment by Application
  2.4.1 Home Use
  2.4.2 Medical Institutions
  2.4.3 Others
2.5 Oral Antidiabetic Agents Market Size by Application
  2.5.1 Oral Antidiabetic Agents Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Oral Antidiabetic Agents Market Size Market Share by Application (2017-2022)

3 ORAL ANTIDIABETIC AGENTS MARKET SIZE BY PLAYER

3.1 Oral Antidiabetic Agents Market Size Market Share by Players
  3.1.1 Global Oral Antidiabetic Agents Revenue by Players (2020-2022)
  3.1.2 Global Oral Antidiabetic Agents Revenue Market Share by Players (2020-2022)
3.2 Global Oral Antidiabetic Agents Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ORAL ANTIDIABETIC AGENTS BY REGIONS

4.1 Oral Antidiabetic Agents Market Size by Regions (2017-2022)
4.2 Americas Oral Antidiabetic Agents Market Size Growth (2017-2022)
4.3 APAC Oral Antidiabetic Agents Market Size Growth (2017-2022)
4.4 Europe Oral Antidiabetic Agents Market Size Growth (2017-2022)
4.5 Middle East & Africa Oral Antidiabetic Agents Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Oral Antidiabetic Agents Market Size by Country (2017-2022)
5.2 Americas Oral Antidiabetic Agents Market Size by Type (2017-2022)
5.3 Americas Oral Antidiabetic Agents Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral Antidiabetic Agents Market Size by Region (2017-2022)
6.2 APAC Oral Antidiabetic Agents Market Size by Type (2017-2022)
6.3 APAC Oral Antidiabetic Agents Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oral Antidiabetic Agents by Country (2017-2022)
7.2 Europe Oral Antidiabetic Agents Market Size by Type (2017-2022)
7.3 Europe Oral Antidiabetic Agents Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral Antidiabetic Agents by Region (2017-2022)
8.2 Middle East & Africa Oral Antidiabetic Agents Market Size by Type (2017-2022)
8.3 Middle East & Africa Oral Antidiabetic Agents Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ORAL ANTIDIABETIC AGENTS MARKET FORECAST

10.1 Global Oral Antidiabetic Agents Forecast by Regions (2023-2028)
  10.1.1 Global Oral Antidiabetic Agents Forecast by Regions (2023-2028)
  10.1.2 Americas Oral Antidiabetic Agents Forecast
  10.1.3 APAC Oral Antidiabetic Agents Forecast
  10.1.4 Europe Oral Antidiabetic Agents Forecast
  10.1.5 Middle East & Africa Oral Antidiabetic Agents Forecast
10.2 Americas Oral Antidiabetic Agents Forecast by Country (2023-2028)
  10.2.1 United States Oral Antidiabetic Agents Market Forecast
  10.2.2 Canada Oral Antidiabetic Agents Market Forecast
  10.2.3 Mexico Oral Antidiabetic Agents Market Forecast
  10.2.4 Brazil Oral Antidiabetic Agents Market Forecast
10.3 APAC Oral Antidiabetic Agents Forecast by Region (2023-2028)
  10.3.1 China Oral Antidiabetic Agents Market Forecast
  10.3.2 Japan Oral Antidiabetic Agents Market Forecast
  10.3.3 Korea Oral Antidiabetic Agents Market Forecast
  10.3.4 Southeast Asia Oral Antidiabetic Agents Market Forecast
  10.3.5 India Oral Antidiabetic Agents Market Forecast
  10.3.6 Australia Oral Antidiabetic Agents Market Forecast
10.4 Europe Oral Antidiabetic Agents Forecast by Country (2023-2028)
  10.4.1 Germany Oral Antidiabetic Agents Market Forecast
  10.4.2 France Oral Antidiabetic Agents Market Forecast
  10.4.3 UK Oral Antidiabetic Agents Market Forecast
  10.4.4 Italy Oral Antidiabetic Agents Market Forecast
  10.4.5 Russia Oral Antidiabetic Agents Market Forecast
10.5 Middle East & Africa Oral Antidiabetic Agents Forecast by Region (2023-2028)
  10.5.1 Egypt Oral Antidiabetic Agents Market Forecast
  10.5.2 South Africa Oral Antidiabetic Agents Market Forecast
  10.5.3 Israel Oral Antidiabetic Agents Market Forecast
  10.5.4 Turkey Oral Antidiabetic Agents Market Forecast
  10.5.5 GCC Countries Oral Antidiabetic Agents Market Forecast
10.6 Global Oral Antidiabetic Agents Forecast by Type (2023-2028)
10.7 Global Oral Antidiabetic Agents Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 Novo Nordisk
  11.1.1 Novo Nordisk Company Information
  11.1.2 Novo Nordisk Oral Antidiabetic Agents Product Offered
  11.1.3 Novo Nordisk Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 Novo Nordisk Main Business Overview
  11.1.5 Novo Nordisk Latest Developments
11.2 Eli Lilly
  11.2.1 Eli Lilly Company Information
  11.2.2 Eli Lilly Oral Antidiabetic Agents Product Offered
  11.2.3 Eli Lilly Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 Eli Lilly Main Business Overview
  11.2.5 Eli Lilly Latest Developments
11.3 Sanofi
  11.3.1 Sanofi Company Information
  11.3.2 Sanofi Oral Antidiabetic Agents Product Offered
  11.3.3 Sanofi Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Sanofi Main Business Overview
  11.3.5 Sanofi Latest Developments
11.4 Roche
  11.4.1 Roche Company Information
  11.4.2 Roche Oral Antidiabetic Agents Product Offered
  11.4.3 Roche Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 Roche Main Business Overview
  11.4.5 Roche Latest Developments
11.5 Teva
  11.5.1 Teva Company Information
  11.5.2 Teva Oral Antidiabetic Agents Product Offered
  11.5.3 Teva Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 Teva Main Business Overview
  11.5.5 Teva Latest Developments
11.6 AstraZeneca
  11.6.1 AstraZeneca Company Information
  11.6.2 AstraZeneca Oral Antidiabetic Agents Product Offered
  11.6.3 AstraZeneca Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2022)
  11.6.4 AstraZeneca Main Business Overview
  11.6.5 AstraZeneca Latest Developments
11.7 Wockhardt UK
  11.7.1 Wockhardt UK Company Information
  11.7.2 Wockhardt UK Oral Antidiabetic Agents Product Offered
  11.7.3 Wockhardt UK Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2022)
  11.7.4 Wockhardt UK Main Business Overview
  11.7.5 Wockhardt UK Latest Developments
11.8 Merck
  11.8.1 Merck Company Information
  11.8.2 Merck Oral Antidiabetic Agents Product Offered
  11.8.3 Merck Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2022)
  11.8.4 Merck Main Business Overview
  11.8.5 Merck Latest Developments
11.9 Pfizer
  11.9.1 Pfizer Company Information
  11.9.2 Pfizer Oral Antidiabetic Agents Product Offered
  11.9.3 Pfizer Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2022)
  11.9.4 Pfizer Main Business Overview
  11.9.5 Pfizer Latest Developments
11.10 Cipla
  11.10.1 Cipla Company Information
  11.10.2 Cipla Oral Antidiabetic Agents Product Offered
  11.10.3 Cipla Oral Antidiabetic Agents Revenue, Gross Margin and Market Share (2020-2022)
  11.10.4 Cipla Main Business Overview
  11.10.5 Cipla Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oral Antidiabetic Agents Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Sulfonylureas
Table 3. Major Players of Meglitinides
Table 4. Major Players of Biguanides
Table 5. Major Players of Thiazolidinediones
Table 6. Major Players of Alpha-glucosidase Inhibitors
Table 7. Oral Antidiabetic Agents Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Oral Antidiabetic Agents Market Size by Type (2017-2022) & ($ Millions)
Table 9. Global Oral Antidiabetic Agents Market Size Market Share by Type (2017-2022)
Table 10. Oral Antidiabetic Agents Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Oral Antidiabetic Agents Market Size by Application (2017-2022) & ($ Millions)
Table 12. Global Oral Antidiabetic Agents Market Size Market Share by Application (2017-2022)
Table 13. Global Oral Antidiabetic Agents Revenue by Players (2020-2022) & ($ Millions)
Table 14. Global Oral Antidiabetic Agents Revenue Market Share by Player (2020-2022)
Table 15. Oral Antidiabetic Agents Key Players Head office and Products Offered
Table 16. Oral Antidiabetic Agents Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oral Antidiabetic Agents Market Size by Regions 2017-2022 & ($ Millions)
Table 20. Global Oral Antidiabetic Agents Market Size Market Share by Regions (2017-2022)
Table 21. Americas Oral Antidiabetic Agents Market Size by Country (2017-2022) & ($ Millions)
Table 22. Americas Oral Antidiabetic Agents Market Size Market Share by Country (2017-2022)
Table 23. Americas Oral Antidiabetic Agents Market Size by Type (2017-2022) & ($ Millions)
Table 24. Americas Oral Antidiabetic Agents Market Size Market Share by Type (2017-2022)
Table 25. Americas Oral Antidiabetic Agents Market Size by Application (2017-2022) & ($ Millions)
Table 26. Americas Oral Antidiabetic Agents Market Size Market Share by Application (2017-2022)
Table 27. APAC Oral Antidiabetic Agents Market Size by Region (2017-2022) & ($ Millions)
Table 28. APAC Oral Antidiabetic Agents Market Size Market Share by Region (2017-2022)
Table 29. APAC Oral Antidiabetic Agents Market Size by Type (2017-2022) & ($ Millions)
Table 30. APAC Oral Antidiabetic Agents Market Size Market Share by Type (2017-2022)
Table 31. APAC Oral Antidiabetic Agents Market Size by Application (2017-2022) & ($ Millions)
Table 32. APAC Oral Antidiabetic Agents Market Size Market Share by Application (2017-2022)
Table 33. Europe Oral Antidiabetic Agents Market Size by Country (2017-2022) & ($ Millions)
Table 34. Europe Oral Antidiabetic Agents Market Size Market Share by Country (2017-2022)
Table 35. Europe Oral Antidiabetic Agents Market Size by Type (2017-2022) & ($ Millions)
Table 36. Europe Oral Antidiabetic Agents Market Size Market Share by Type (2017-2022)
Table 37. Europe Oral Antidiabetic Agents Market Size by Application (2017-2022) & ($ Millions)
Table 38. Europe Oral Antidiabetic Agents Market Size Market Share by Application (2017-2022)
Table 39. Middle East & Africa Oral Antidiabetic Agents Market Size by Region (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Oral Antidiabetic Agents Market Size Market Share by Region (2017-2022)
Table 41. Middle East & Africa Oral Antidiabetic Agents Market Size by Type (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Oral Antidiabetic Agents Market Size Market Share by Type (2017-2022)
Table 43. Middle East & Africa Oral Antidiabetic Agents Market Size by Application (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Oral Antidiabetic Agents Market Size Market Share by Application (2017-2022)
Table 45. Key Market Drivers & Growth Opportunities of Oral Antidiabetic Agents
Table 46. Key Market Challenges & Risks of Oral Antidiabetic Agents
Table 47. Key Industry Trends of Oral Antidiabetic Agents
Table 48. Global Oral Antidiabetic Agents Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 49. Global Oral Antidiabetic Agents Market Size Market Share Forecast by Regions (2023-2028)
Table 50. Global Oral Antidiabetic Agents Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 51. Global Oral Antidiabetic Agents Market Size Market Share Forecast by Type (2023-2028)
Table 52. Global Oral Antidiabetic Agents Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 53. Global Oral Antidiabetic Agents Market Size Market Share Forecast by Application (2023-2028)
Table 54. Novo Nordisk Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 55. Novo Nordisk Oral Antidiabetic Agents Product Offered
Table 56. Novo Nordisk Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 57. Novo Nordisk Main Business
Table 58. Novo Nordisk Latest Developments
Table 59. Eli Lilly Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 60. Eli Lilly Oral Antidiabetic Agents Product Offered
Table 61. Eli Lilly Main Business
Table 62. Eli Lilly Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 63. Eli Lilly Latest Developments
Table 64. Sanofi Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 65. Sanofi Oral Antidiabetic Agents Product Offered
Table 66. Sanofi Main Business
Table 67. Sanofi Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 68. Sanofi Latest Developments
Table 69. Roche Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 70. Roche Oral Antidiabetic Agents Product Offered
Table 71. Roche Main Business
Table 72. Roche Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 73. Roche Latest Developments
Table 74. Teva Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 75. Teva Oral Antidiabetic Agents Product Offered
Table 76. Teva Main Business
Table 77. Teva Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 78. Teva Latest Developments
Table 79. AstraZeneca Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 80. AstraZeneca Oral Antidiabetic Agents Product Offered
Table 81. AstraZeneca Main Business
Table 82. AstraZeneca Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 83. AstraZeneca Latest Developments
Table 84. Wockhardt UK Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 85. Wockhardt UK Oral Antidiabetic Agents Product Offered
Table 86. Wockhardt UK Main Business
Table 87. Wockhardt UK Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 88. Wockhardt UK Latest Developments
Table 89. Merck Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 90. Merck Oral Antidiabetic Agents Product Offered
Table 91. Merck Main Business
Table 92. Merck Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 93. Merck Latest Developments
Table 94. Pfizer Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 95. Pfizer Oral Antidiabetic Agents Product Offered
Table 96. Pfizer Main Business
Table 97. Pfizer Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 98. Pfizer Latest Developments
Table 99. Cipla Details, Company Type, Oral Antidiabetic Agents Area Served and Its Competitors
Table 100. Cipla Oral Antidiabetic Agents Product Offered
Table 101. Cipla Main Business
Table 102. Cipla Oral Antidiabetic Agents Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 103. Cipla Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Oral Antidiabetic Agents Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral Antidiabetic Agents Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Oral Antidiabetic Agents Market Size Market Share by Type in 2021
Figure 7. Oral Antidiabetic Agents in Home Use
Figure 8. Global Oral Antidiabetic Agents Market: Home Use (2017-2022) & ($ Millions)
Figure 9. Oral Antidiabetic Agents in Medical Institutions
Figure 10. Global Oral Antidiabetic Agents Market: Medical Institutions (2017-2022) & ($ Millions)
Figure 11. Oral Antidiabetic Agents in Others
Figure 12. Global Oral Antidiabetic Agents Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Oral Antidiabetic Agents Market Size Market Share by Application in 2021
Figure 14. Global Oral Antidiabetic Agents Revenue Market Share by Player in 2021
Figure 15. Global Oral Antidiabetic Agents Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Oral Antidiabetic Agents Market Size 2017-2022 ($ Millions)
Figure 17. APAC Oral Antidiabetic Agents Market Size 2017-2022 ($ Millions)
Figure 18. Europe Oral Antidiabetic Agents Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Oral Antidiabetic Agents Market Size 2017-2022 ($ Millions)
Figure 20. Americas Oral Antidiabetic Agents Value Market Share by Country in 2021
Figure 21. Americas Oral Antidiabetic Agents Consumption Market Share by Type in 2021
Figure 22. Americas Oral Antidiabetic Agents Market Size Market Share by Application in 2021
Figure 23. United States Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Oral Antidiabetic Agents Market Size Market Share by Region in 2021
Figure 28. APAC Oral Antidiabetic Agents Market Size Market Share by Application in 2021
Figure 29. China Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Oral Antidiabetic Agents Market Size Market Share by Country in 2021
Figure 36. Europe Oral Antidiabetic Agents Market Size Market Share by Type in 2021
Figure 37. Europe Oral Antidiabetic Agents Market Size Market Share by Application in 2021
Figure 38. Germany Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Oral Antidiabetic Agents Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Oral Antidiabetic Agents Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Oral Antidiabetic Agents Market Size Market Share by Application in 2021
Figure 46. Egypt Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Oral Antidiabetic Agents Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 52. APAC Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 53. Europe Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 55. United States Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 56. Canada Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 59. China Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 60. Japan Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 61. Korea Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 63. India Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 64. Australia Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 65. Germany Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 66. France Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 67. UK Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 68. Italy Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 69. Russia Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 70. Spain Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 73. Israel Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Oral Antidiabetic Agents Market Size 2023-2028 ($ Millions)